CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus

European Journal of Dermatology

Volumn 22, Issue 4, 2012, Pages 512-517

  Nakayama, Wakana ^a   Jinnin, Masatoshi ^a   Makino, Katsunari ^a   Kajihara, Ikko ^a   Makino, Takamitsu ^a   Fukushima, Satoshi ^a   Sakai, Keisuke ^a   Inoue, Yuji ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Collagen disease; Disease severity; Leukopenia; Macrophage

Indexed keywords

CD163 ANTIGEN; DOUBLE STRANDED DNA ANTIBODY; MESSENGER RNA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; LEUKOPENIA; MACROPHAGE; MALE; PERICARDITIS; PHOTOSENSITIVITY; PREVALENCE; PROTEINURIA; RASH; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SKIN; YOUNG ADULT;

EID: 84865383712     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1756     Document Type: Article

References (31)

1. Hahn BH. Systemic Lupus Erythematosus. New York: McGraw-Hill, 2005:1956-67.
2. Marshak-Rothstein A. Tolling for autoimmunity-prime time for 7. Immunity 2006; 25: 397-9.
3. Theofilopoulos AN, Baccala R, Beutler B et al. Type I interferons in immunity and autoimmunity. Annu Rev Immunol 2005; 23: 307-36.
4. Unanue ER. The regulation of lymphocyte functions by the macrophage. Immunol Rev 1978; 40: 227-55.
5. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-64.
6. Katsiari C, Liossis S, Sfikakis P. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum 2010; 39: 491-503.
7. Li Y, Lee P, Reeves W. Monocyte and macrophage abnormalities in systemic lupus erythematous. Arch Immunol Ther Exp 2010; 58: 355-64.
8. Rho YH, Solus J, Raggi P et al. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res 2011; 63: 535-41.
9. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
10. Higashi-Kuwata N, Makino T, Inoue Y et al. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp Dermatol 2009; 18: 727-9.
11. Mosser D. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-12.
12. Mantovani A, Sica A, Sozzani S et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86.
13. Komohara Y, Hirahara J, Horikawa T et al. AM-3K, an antimacrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006; 54: 763-71.
14. Martinez F, Gordon S, Locati M et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-11.
15. Avrǎmescu C, Biciuscǎ V, Dǎianu T et al. Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Rom J Morphol Embryol 2010; 51: 633-40.
16. Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 2008; 29: 105-12.
17. Morimoto S, Tokano Y, Kaneko H et al. The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings. Autoimmunity 2000; 34: 19-25.
18. Liu TF, Jones BM. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 1998; 10: 140-7.
19. Llorente L, Richaud-Patin Y, Wijdenes J et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4: 421-7.
20. Nakayama W, Jinnin M, Makino K et al. Serum levels of soluble CD163 in patients with systemic sclerosis. Rheumatol Int 2010;32(2):403-7.
21. Sulahian T, Hintz K, Wardwell K et al. Development of an ELISA to measure soluble CD163 in biological fluids. J Immunol Methods 2001; 252: 25-31.
22. Baeten D, Moller H, Delanghe J et al. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum 2004; 50: 1611-23.
23. Hiraoka A, Horiike N, Akbar S et al. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005; 40: 52-6.
24. Kawamura K, Komohara Y, Takaishi K et al. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 2009; 59: 300-5.
25. Matsushita N, Kashiwagi M, Wait R et al. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol 2002; 130: 156-61.
26. Bruns A, Meyer O. Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine 2006; 73: 639-45.
27. Borchers AT, Aoki CA, Naguwa SM et al. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun Rev 2005; 4: 329-44.
28. Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 2004; 127: 1200-9.
29. Singer J, Denburg JA. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The Ad Hoc Neuropsychiatric Lupus Workshop Group. J Rheumatol 1990; 17: 1397-402.
30. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357-64.
31. Brey RL. Neuropsychiatric lupus: clinical and imaging aspects. Bull NYU Hosp Jt Dis 2007; 65: 194-9.